Blood · 2004 · 37 citations · 48 references
Life SciencesBiochemistryMolecular BiologyHemostasisProtein BiochemistryAnticoagulation TherapyCoagulation AbnormalitiesPlasma ProteinsThrombosis PreventionAnticoagulant MechanismsEnzyme Cofactor ActivityNatural Anticoagulant ProteinsPlasma Anticoagulant ActivityProtein C SystemProtein Cofactor InteractionsProtein S Function
We expressed 2 chimeras between human protein S (PS) and human prothrombin (FII) in which the prothrombin gamma-carboxyglutamic acid (Gla) domain replaced the PS Gla domain in native PS (Gla(FII)-PS) or in PS deleted of the thrombin-sensitive region (TSR) (Gla(FII)-DeltaTSR-PS). Neither PS/FII chimera had activated protein C (APC) cofactor activity in plasma clotting assays or purified systems, but both bound efficiently to phospholipids. This pointed to a direct involvement of the PS Gla domain in APC cofactor activity through molecular interaction with APC. Using computational methods, we identified 2 opposite faces of solvent-exposed residues on the PS Gla domain (designated faces 1 and 2) as potentially involved in this interaction. Their importance was supported by functional characterization of a PS mutant in which the face 1 and face 2 PS residues were reintroduced into Gla(FII)-PS, leading to significant APC cofactor activity, likely through restored interaction with APC. Furthermore, by characterizing PS mutants in which PS face 1 and PS face 2 were individually replaced by the corresponding prothrombin faces, we found that face 1 was necessary for efficient phospholipid binding but that face 2 residues were not strictly required for phospholipid binding and were involved in the interaction with APC.
48
Michael J. Hope, Marcel B. Bally, G. A. Webb et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1985 · 2.1K citations
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor
David W. Banner, A. D’Arcy, C. Chene et al. · Nature · 1996 · 733 citations
Life Sciences, Biochemistry, Biology +15